PIERIS PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
42 Contracts & Agreements
- Exchange Agreements (4 contracts)
- Investment Agreements (2)
- Loan Agreements (3)
- Note Agreements (2)
- Participation Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (5)
- Release Agreements (1)
- Shareholders Agreements (1)
- Stock Agreements (10)
- Subscription Agreements (2)
- Underwriting Agreements (2)
- Waiver Agreements (1)
- Warrant Agreements (4)
- Form of Notice of Grant of Restricted Stock Units Award (Filed With SEC on December 16, 2024)
- Form of Stock Option Grant Notice and Stock Option Agreement (Filed With SEC on December 16, 2024)
- Registration Rights Agreement, dated as of December 13, 2024, by and among Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.) and certain purchasers (Filed With SEC on December 16, 2024)
- Form of Common Stock Certificate (Filed With SEC on December 16, 2024)
- Form of Common Stock Certificate (Filed With SEC on August 14, 2024)
- Form of 2024 Convertible Note Purchase Agreement (Filed With SEC on August 9, 2024)
- Form of Convertible Promissory Note (Filed With SEC on August 9, 2024)
- Subscription and Investment Representation Agreement, dated August 7, 2024, by and between Pieris Pharmaceuticals, Inc. and James Geraghty (Filed With SEC on August 8, 2024)
- Form of Registration Rights Agreement (Filed With SEC on July 24, 2024)
- Securities Purchase Agreement, dated as of July 23, 2024, by and among Pieris Pharmaceuticals, Inc. and certain purchasers (Filed With SEC on July 24, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on July 24, 2024)
- Pieris Pharmaceutical, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on August 10, 2023)
- Pieris Pharmaceutical, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on June 26, 2023)
- Exchange Agreement by and among Pieris Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., and... (Filed With SEC on May 21, 2021)
- Subscription Agreement, dated March 29, 2021, by and between Pieris Pharmaceuticals, Inc. and AstraZeneca AB (Filed With SEC on May 17, 2021)
- Subscription Agreement, dated March 24, 2021, by and between Pieris Pharmaceuticals, Inc. and Seagen Inc (Filed With SEC on May 17, 2021)
- Exchange Agreement by and among Pieris Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., and Biotechnology Value Trading Fund OS, L.P.,... (Filed With SEC on April 6, 2020)
- Non-Qualified Stock Option Agreement by and between the Registrant and Hitto Kaufmann, Ph.D., dated as of August 30, 2019 (Filed With SEC on November 12, 2019)
- Registration Rights Agreement, dated November 2, 2019, by and among the Company and the Investors named therein (Filed With SEC on November 4, 2019)
- Form of Warrant to purchase Common Stock (Filed With SEC on November 4, 2019)
- Securities Purchase Agreement, dated November 2, 2019, by and among the Company and the Investors named therein (Filed With SEC on November 4, 2019)
- Exchange Agreement by and among Pieris Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., and Biotechnology Value Trading Fund OS, L.P.,... (Filed With SEC on February 4, 2019)
- Pieris Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on July 26, 2018)
- Underwriting Agreement, dated February 14, 2018, by and among the Company, Jefferies LLC, Cowen and Company, LLC, and Evercore Group L.L.C (Filed With SEC on February 14, 2018)
- Stock Option Agreement, dated August 9, 2017, between Pieris Pharmaceuticals Inc. and Allan Reine,.M.D (Filed With SEC on November 13, 2017)
- LICENSE AND COLLABORATION AGREEMENT BETWEEN LESLABORATOIRES SERVIER INSTITUT DE RECHERCHES INTERNATIONALES SERVIER AND PIERISPHARMACEUTICALS, INC. PIERIS PHARMACEUTICALS GMBH... (Filed With SEC on March 30, 2017)
- PIERIS PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on October 5, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 6, 2016)
- PIERIS PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK Original Issue Date: June , 2016 (Filed With SEC on June 6, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 6, 2016)
- Shares Pieris Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 24, 2015)
- COMMON STOCK PURCHASE WARRANT PIERIS PHARMACEUTICALS, INC. (Filed With SEC on December 23, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 23, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 23, 2014)
- GENERAL RELEASE AGREEMENT (Filed With SEC on December 18, 2014)
- Investment Agreement Pieris AG, Freising, Germany dated October 10, 2014 by and among (Filed With SEC on December 18, 2014)
- Consolidated Shareholders Agreement 2014 Pieris AG, Freising, Germany dated October 10, 2014 by and among (Filed With SEC on December 18, 2014)
- Convertible Bridge Loan Agreement Dated April 14, 2014 between (Filed With SEC on December 18, 2014)
- PARTICIPATION AGREEMENT Contract on the establishment of a silent partnership (Filed With SEC on December 18, 2014)
- Amendment to the Convertible Bridge Loan Agreement dated November 12, 2012 between (Filed With SEC on December 18, 2014)
